Filter
545
Filtered Results: 545
Text search:
Rational
Pharmaceutical
Management
Project
Featured
Recommendations
48
New Publications
178
Language
Document type
No document type
311
Studies & Reports
94
Guidelines
72
Strategic & Response Plan
23
Manuals
20
Training Material
13
Situation Updates
7
Fact sheets
4
Brochures
1
Countries / Regions
Kenya
30
Ethiopia
25
India
19
Zambia
17
Global
16
Uganda
16
Sierra Leone
14
Nigeria
14
Western and Central Europe
14
Liberia
13
Ghana
11
Rwanda
11
Tanzania
10
Namibia
10
Nepal
9
Philippines
9
Malawi
8
Eastern Europe
8
Cambodia
6
South Africa
6
Myanmar / Burma
6
Eswatini/ Swaziland
6
Lesotho
5
Africa
5
Bangladesh
5
Indonesia
5
Zimbabwe
4
Latin America and the Carribbean
4
Thailand
3
Ukraine
3
Cameroon
3
Asia
3
Congo, Democratic Republic of
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Botswana
3
South Sudan
3
China
2
Mozambique
2
Haiti
2
Jordan
2
Germany
2
Vietnam
2
North Macedonia
1
Tajikistan
1
Benin
1
Syria
1
Albania
1
Laos
1
Senegal
1
Burkina Faso
1
Peru
1
USA
1
Western Pacific Region
1
Gabon
1
Turkmenistan
1
Belgium
1
Russia
1
Sudan
1
Central African Republic
1
Mali
1
Libya
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
258
Public Health
29
Clinical Guidelines
29
Key Resources
27
Women & Child Health
9
Pharmacy & Technologies
9
Capacity Building
4
Annual Report MEDBOX
2
Toolboxes
AMR
83
Pharmacy
48
TB
34
Mental Health
19
HIV
15
NCDs
14
Rapid Response
12
NTDs
12
COVID-19
11
Planetary Health
11
Global Health Education
10
Caregiver
7
Health Financing Toolbox
5
Ebola & Marburg
4
Refugee
3
Natural Hazards
3
Conflict
3
Disability
2
Polio
2
Specific Hazards
1
Zika
1
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re...
The Facilitator’s Guide for the basic-needs based Response Options Analysis and Planning (ROAP) is a step-by-step guide comprising tools and templates to carry out a multi-sectoral response analysis and planning of response options, in a sudden-onset or chronic crisis.
Being that so, the Guide i...
The Facilitator's Guide has been piloted in Borno (Nigeria) and in Fafan zone (Somali region, Ethiopia) and improved iteratively after each test.
What does the ROAP have that you won't find in other methodologies?
It is based on holistic, people-centred approaches that span across sectors an...
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
this Service Delivery brief provides evidence-based strategies that can help support drug shops and pharmacies in providing a wider variety of family planning methods and information. Evidence shows that with training and support, pharmacy and drug shop staff can facilitate the use of a broad range ...
World Health Organization, Food and Agriculture Organization of the United Nations & World Organisation for Animal Health. (2021). Antimicrobial resistance and the United Nations sustainable development cooperation framework: guidance for United Nations country teams. World Health Organization
Zero new HIV infections
Zero Discrimination
Zero AIDS related deaths
Accessed: 04.10.2019
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
